Kimelman & Baird, LLC Eli Lilly & CO Transaction History
Kimelman & Baird, LLC
- $1.21 Trillion
- Q2 2024
A detailed history of Kimelman & Baird, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kimelman & Baird, LLC holds 37,960 shares of LLY stock, worth $30.3 Million. This represents 2.83% of its overall portfolio holdings.
Number of Shares
37,960
Previous 64,000
40.69%
Holding current value
$30.3 Million
Previous $14.7 Million
233872.53%
% of portfolio
2.83%
Previous 1.31%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
3,920Shares Held
765MCall Options Held
6.38MPut Options Held
7.95M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$77.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$58.9 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.5 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$27 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $758B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...